Presented in part at the American Society of Clinical Oncology, Chicago, IL, June 2012.
A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study
Article first published online: 24 MAR 2014
© 2014 Wiley Periodicals, Inc.
Pediatric Blood & Cancer
Volume 61, Issue 7, pages 1246–1251, July 2014
How to Cite
Fouladi, M., Perentesis, J. P., Phillips, C. L., Leary, S., Reid, J. M., McGovern, R. M., Ingle, A. M., Ahern, C. H., Ames, M. M., Houghton, P., Doyle, L. A., Weigel, B. and Blaney, S. M. (2014), A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study. Pediatr. Blood Cancer, 61: 1246–1251. doi: 10.1002/pbc.25023
Conflict of interest: Nothing to declare.
- Issue published online: 2 MAY 2014
- Article first published online: 24 MAR 2014
- Manuscript Accepted: 30 JAN 2014
- Manuscript Received: 1 NOV 2013
- National Cancer Institute. Grant Numbers: U01 CA97452, UM1 CA097452-11
- Cancerfree KIDS
Additional supporting information may be found in the online version of this article at the publisher's web-site.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.